Take-home Messages

Presentation TCT 2015

HOT TOPIC 2: Balancing Safety and Efficacy Endpoints – How Do “Net Clinical Benefit” and “Quality of Life” Fit Into the Equation? FOCUS on DAPT, PEGASUS, and MATRIX: Clinical/Trialist Perspective

Presenter: Gregg W. Stone

October 12, 2015

Presentation TCT 2015

ABSORB II: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease - Two-Year Outcomes

Presenter: Bernard R. Chevalier

October 12, 2015